Relative prevalence of comorbidities and treatment contraindications in HIV-mono-infected and HIV/HCV-co-infected veterans

AIDS

Volumn 19, Issue SUPPL. 3, 2005, Pages

  Goulet, Joseph L ^a,b,d   Fultz, Shawn L ^a,b   McGinnis, Kathleen A ^c   Justice, Amy C ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d YALE UNIVERSITY   (United States)

Author keywords

Comorbidity; Factor analysis; Hepatitis C virus; HIV; Mental disorders; Veterans

Indexed keywords

ALCOHOL;

ADULT; AGED; ALCOHOLISM; ANEMIA; ARTICLE; ASTHMA; BIPOLAR DISORDER; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DATA ANALYSIS; DEMOGRAPHY; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; ELECTRONIC MEDICAL RECORD; FACTORIAL ANALYSIS; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; HYPERTENSION; INTERNATIONAL CLASSIFICATION OF DISEASES; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PANCREATITIS; PATIENT CODING; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; SAMPLE; SCHIZOPHRENIA; SOLDIER; STATISTICAL SIGNIFICANCE; STROKE; TRANSIENT ISCHEMIC ATTACK; VALIDATION PROCESS;

EID: 27944446862     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000192077.11067.e5     Document Type: Article

References (29)

1. Soriano V, Rodriguez-Rosado R, Garcia-Samaniego J. Management of chronic hepatitis C in HIV-infected patients. AIDS 1999; 13:539-546.
2. Mildvan D. Implications of anemia in human immunodeficiency virus, cancer, and hepatitis C virus. Clin Infect Dis 2003; 37 (Suppl. 4):293-296.
3. Conigliaro J, Gordon AJ, McGinnis KA, Rabeneck L, Justice AC, for the Veterans Aging Cohort 3-Site Study. How harmful is hazardous alcohol use and abuse in HIV infection: do health care providers know who is at risk? J Acquir Immune Defic Syndr 2003; 33:521-525.
4. Galvan FH, Bing EG, Fleishman JA, London AS, Caetano R, Burnam MA, et al. The prevalence of alcohol consumption and heavy drinking among people with HIV in the United States: results from the HIV Cost and Services Utilization Study. J Stud Alcohol 2002; 63:179-186.
5. Cruess DG, Evans DL, Repetto MJ, Gettes D, Douglas SD, Petitto JM. Prevalence, diagnosis, and pharmacological treatment of mood disorders in HIV disease. Biol Psychiatry 2003; 54:307-316.
6. Kilbourne AM, Justice AC, Rollman BL, McGinnis KA, Rabeneck L, Weissman S, et al. Clinical importance of HIV and depressive symptoms among veterans with HIV infection. J Gen Intern Med 2002; 17:512-520.
7. Dieperink E, Willenbring M, Ho SB. Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: a review. Am J Psychiatry 2000; 157:867-876.
8. Fleming CA, Craven DE, Thornton D, Tumilty S, Nunes D. Hepatitis C virus and human immunodeficiency virus coinfection in an urban population: low eligibility for interferon treatment. Clin Infect Dis 2003; 36:97-100.
9. National Institutes of Health. Management of hepatitis C: 2002. NIH Consens State Sci Statements. 10-12 June 2002; 19:1-46. Available at: http://consensus.nih.gov/cons/105/105_statement.htm. Accessed: 28 April 2004.
10. US Public Health Service and Infectious Disease Society of America (IDSA). 2001 USPHS/IDSA guidelines for the management of opportunistic infections in persons infected with HIV. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service; 2001 Nov 28.
11. Soriano V, Sulkowski M, Bergin C, Hatzakis A, Cacoub P, Katlama C, et al. Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV-HCV International Panel. AIDS 2002; 16:813-828.
12. Gallucci G, Smolinski J. Treatment contracts for patients with hepatitis C, psychiatric illness, and substance abuse. Psychosomatics 2001; 42:353-355.
13. Dobmeier M, Frick E, Frank S, Franke C, Wolfersdorf M. Schizophrenic psychosis: a contraindication for treatment of hepatitis C with interferon alpha? Pharmacopsychiatry 2000; 33:72-74.
14. Trask PC, Esper P, Riba M, Redman B. Psychiatric side effects of interferon therapy: prevalence, proposed mechanisms, and future directions. J Clin Oncol 2000; 18:2316-2326.
15. Schafer M, Boetsch T, Laakmann G. Psychosis in a methadone substituted patient during interferon-alpha treatment of hepatitis C. Addiction 2000; 95:1101-1104.
16. Pessione F, Degos F, Marcellin P, Duchatelle V, Njapoum C, Martinot-Peignoux M, et al. Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C. Hepatology 1998; 27:1717-1722.
17. Strathdee SA, Palepu A, Cornelisse P, Yip B, O'Shaughnessy MV, Montaner JS, et al. Barriers to use of free antiretroviral therapy in injection drug users. JAMA 1998; 280:547-549.
18. Kresina TF, Flexner CW, Sinclair J, Correia MA, Stapleton JT, Adeniyi-Jones S, et al. Alcohol use and HIV pharmacotherapy. AIDS Res Hum Retroviruses 2002; 18:757-770.
19. Schiff ER. The alcoholic patient with hepatitis C virus infection. Am J Med 1999; 107 (Suppl. 6B):95s-99s.
20. Corrigan JM, Eden J, Smith BM, editors. Leadership by example: coordinating government roles in improving health care quality. Committee on Enhancing Federal Healthcare Quality Programs. Washington, DC: The National Academies Press; 2003.
21. Fasciano N, Cherlow A, Turner B, Thornton C. Profile of Medicare beneficiaries with AIDS: application of an AIDS case finding algorithm. Health Care Financ Rev 1998; 19:19-38.
22. McGinnis KA, Fine MJ, Sharma RK, Skanderson M, Wagner JH, Rodriguez-Barradas MC, et al. Understanding racial disparities in HIV using data from the Veterans Aging Cohort 3-Site Study and VA administrative data. Am J Public Health 2003; 93:1728-1733.
23. Druss BG, Rosenheck RA. Locus of mental health treatment in an integrated service system. Psychiatr Serv 2000; 51:890-892.
24. Fleiss JL. Measuring nominal scale agreement among many raters. Psychol Bull 1971; 76:378-382.
25. Landis RJ, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33:159-174.
26. Drasgow F. Polychoric and polyserial correlations. In Kotz L, Johnson NL, editors. Encyclopedia of statistical sciences, Vol. 7. New York: Wiley; 1988. pp. 69-74.
27. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341:556-562.
28. Roselle GA, Danko LH, Kralovic SM, Simbartl LA, Kizer KW. National hepatitis C surveillance day in the Veterans Health Administration of the Department of Veterans Affairs. Military Med 2002; 167:756-759.
29. Justice AC, Landefeld SC, Asch SM, Gifford A, Whalen C, Covinsky K. Justification for a new cohort study of people aging with and without HIV infection. J Clin Epidemiol 2001; 54 (Suppl. 1):S3-S8.